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1. Introduction 
Soybean (Glycine max MERILL), first grown in Eastern Asia thousands of years ago, have 
long been important protein sources, complementing grain proteins, in Asian countries. In 
addition to essential nutrients, soybean products, especially fermented soybean products, 
contain various functional components including peptides, isoflavonoids and more (Davis 
et al., 2005). Due to these nutritional and functional facts, soybean products were included 
in the world’s top 5 healthiest foods in magazine ‘Health (2006)’: Due to dozens of studies 
showing soy is good for your heart; the FDA even allows certain soy products to have a 
heart-healthy claim on their labels. A number of epidemiological studies have suggested 
that consumption of soybeans and soy foods is associated with lowered risks for several 
cancers including breast, prostate, and colon, and cardiovascular diseases (Anderson et al., 
1998; P.C. Butler et al., 2007; Messina, 1995; Peterson & Barnes, 1991, 1993) and improves 
bone health (Bhathena & Velasquez, 2002). Furthermore, some studies have shown that a 
diet rich in soy can reduce breast cancer risk (Messina, 1999a, 1999b).  
Fermentation is one of the major processes used in the production of food from soybeans. 
Fermented soybean paste is indigenous to the cuisines of East and Southeast Asia. 
Bibliographically, Korea developed and used its own traditional fermented foods two 
thousand years ago (Kwon et al., 2011a). Korean soy foods are increasingly present on the 
worldwide market, and because kochujang (fermented red pepper paste with soybean flour) 
and fermented soybean pastes (doenjang and chungkukjang; both chungkukjang and 
chungkookjang are used in the reports) were registered in CODEX in July, 2009, they are 
now internationally accepted foods (Kwon et al., 2010). Most fermented soybean pastes are 
salty and savory and some are spicy. They are often used as condiments to flavor foods such 
as stir-fries, stews, and soups. This fermentation changes the physico-chemical and 
organoleptic properties of soy products such as color, flavor and active components. 
www.intechopen.com
 Soybean and Health 22
Differences in their color, flavor and active components are due to different production 
methods such as the conditions of fermentation; the addition of wheat flour, pulverized 
meju, rice; and the presence of different microflora such as bacteria or yeasts used in their 
production, as well as whether the soybeans are roasted (as in chunjang) or aged (as in 
tauchu) before being ground. In addition to physicochemical properties, the fermentation of 
these soybean products changes the bioactive components, such as isoflavonoids and 
peptides, in ways which may alter their physiological properties in terms of healthy 
functions and efficacies.  
Although soybean is well known to be good for preventing obesity, diabetes, heart disease 
and breast cancer, the scientific evidence for these health effects are not well enough 
documented to satisfy the inquisitiveness of oriental fermented foods. The need to satisfy 
this curiosity is increasing, so we have investigated the health effect of Korean traditional 
fermented foods, identified the active compounds produced during fermentation and the 
possible mechanisms that support and challenge the hypothesis. Also we designed the new 
noble compounds based on the structure which was isolated from fermented soybeans 
products by modeling the active conformation of linear peptides. Metabolic diseases such as 
obesity, diabetes and cardiovascular diseases that are very close related with dietary foods 
are the focus of this study. 
Here we introduced the fermented soybean foods and discussed their compositional 
changes that occur during fermentation to obtain scientific evidence for the health effects 
and possible mechanism of action of these fermented soybean products. We reviewed the 
epidemiologic studies, cellular/animal experiments or metabolomic approached studies 
about soybeans and fermented soybeans and the most of the research reviewed here was 
performed by our research teams.  
2. Korean fermented soybean products 
We already described the typical fermented soybean foods are consumed in Asian countries 
such as Korea, China, Japan, Indonesia, and Vietnam (Kwon et al., 2010). The most common 
Korean fermented soybean foods are chungkukjang, doenjang, kanjang (soy sauce), and 
kochujang. Originally natto and miso were Japanese versions of chungkukjang and 
doenjang, respectively. China also has various fermented soybean products such as 
doubanjiang, douche (sweet noodle sauce), tauchu (yellow soybean paste), and dajiang. 
Chungkukjang is a short-term fermented soybean product similar to Japanese natto, 
whereas doenjang, kochujang, and kanjang (soy sauce) undergo long term fermentation as 
do Chinese tauchu and Japanese miso (Fig. 1).  
Traditionally chungkukjang was made by fermenting the cooked but non-crushed soybeans 
for two or three days in the living room, usually they prepared chungkukjang in autumn 
and winter after harvesting soybeans. Doenjang and kanjang were prepared by three step 
fermentations: firstly they prepared the meju (dried soybean block) from cooked beans in 
late of October or early of November and fermented it for 1 or 2 months like as solid 
fermentation under the outdoor roof of the Korea traditional house in winter; secondly they 
aged meju for another 1 or 2 months in large earthenware jars by adding a salt solution as 
liquid fermentation, and then they decanted the supernatant liquid to prepare kanjang from 
liquid and doenjang from the remaining soy paste; finally, both liquid and paste were aged 
for longer periods. In comparison, Japanese style doenjang (miso) and kanjang were 
prepared by directly fermenting the cooked soybean without making meju individually. 
www.intechopen.com
 Fermented Soybean Products and Their Bioactive Compounds 23 
Kochujang is a unique and representative Korean traditional food for more than a thousand 
years (Kwon et al., 2011a). Kochujang was usually prepared by mixing powdered red 
peppers, powdered meju, salt, malt-digested rice syrup, and rice flour, and the mixture 
fermented for more than 6 months. 
 
 
Fig. 1. The preparation of Korean fermented products from soybeans 
3. Microorganisms in fermented soybean products 
Meju fermentation is the most important step in producing doenjang and kanjang, because 
many metabolite changes occur during this fermentation, whereas the changes in flavor, 
color and bioactive components were primarily depends on aging after fermentation. 
Chungkukjang, doenjang, kanjang and kochujang are fermented with varying 
microorganisms when traditionally made, because fermentation conditions and ambient 
microbiota are different among regional environments. To make these products by the 
traditional method, cooked soybeans are formed into meju and fermented outdoors by 
micro-organisms naturally present in the environment for 1-2 months. Meju can be 
fermented by traditional methods, being typically fermented primarily by Bacillus species 
during the early stages of fermentation, followed by Aspergillus species, which predominate 
during the remaining fermentation period. Aspergillus oryzae is the major microorganism in 
the final product of meju when it is made in the traditional method. In traditionally 
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fermented chungkukjang, many different bacterial strains were identified by rRNA gene 
sequencing or recA sequence using randomly amplified polymeric DNA-PCR method (G.H. 
Kwon et al., 2009), Bacillus subtilis, B. amyloliquenfaciens, B. licheniformis and B. thuringiensis 
were representative microorganisms during the chungkukjang fermentation. Among them, 
B. subtilis is the predominant strain in traditional chungkukjang fermentation.  
It is well known that poly-Ǆ-glutamate (PGA) and nattokinase (fibrinolytic enzyme) are 
major components for maintaining a healthy immune system (Messina, 1995) and 
cardiovascular system (Sumi et al., 1987), respectively. Fibrinolytic microorganisms screened 
from chungkukjang, doenjang, meju and natto, were identified as B. subtilis, Staphylococcus 
sciuri, Enterococcus faecalis, and Citrobacter or Enterobac ter (Yoon et al., 2002). Even in tempeh 
(Indonesian fermented food), the microorganism producing fibrinolytic enzyme has been 
screened. We isolated B. subtilis from chungkukjang which secreted four different 
fibrinolytic proteases into the culture medium. Also we cloned the  fibrinolytic enzyme 
gene, aprE2, from this B. subtilis into another B. subtilis strain to over-express the enzyme 
successfully using Esherichia coli-Bacillus shuttle vector (Jeong et al., 2007). Sometimes 
chungkukjang became highly viscous due to fibrous PGA polymer accumulation, Ashiuchi 
et al. (2001) isolated strains of B. subtilis from chungkukjang which produced a high contents 
of PGA. 
4. Changes in soybean components by fermentation 
4.1 Nutritional and functional compounds in soybeans  
Soybean products have been known as healthy foods due to being an excellent source of 
high quality protein as well as providing various health benefits. The protein content of 
soybean is 32% to 42%, depending on the variety and growth conditions, of which 
approximately 80% is composed of 2 storage globulins, 7S globulin (ǃ-conglycinin) and 11S 
globulin (glycinin), having various functional and physicochemical properties (Garcia et al., 
1997; Kwon et al., 2002, 2003). Soybean products are considered as a good substitute for 
animal protein, and their nutritional value except sulfur amino acids such as methionine 
and cysteine is almost equivalent to that of animal protein because soy proteins contain 
most of the essential amino acids for human nutrition.  
In addition to high-quality protein, soybeans contain high levels of unsaturated fatty acids, 
dietary fiber, isoflavones and minerals, which possess numerous health benefits (Young, 
1991). In particular, the association of high-quality protein and phytochemicals, especially 
isoflavones, is unique among plant-based proteins because isoflavones are not widely 
distributed in plants other than legumes (Velasquez & Bhathena, 2007). Soybeans contain 0.1 
to 5 mg total isoflavones per gram, primarily genistein, daidzein, and glycitein. These 
nonsteroidal compounds, commonly known as soy phytoestrogens, are naturally present as 
the ǃ-glucosides genistin, daidzin, and glycitin, representing 50% to 55%, 40% to 45%, and 
5% to 10% of the total isoflavone content, respectively (Murphy et al., 1999), depending on 
the soy products (Murphy et al., 1999; Velasquez & Bhathena, 2007; Young, 1991).  
4.2 Changes of nutritional compounds and functional components during 
fermentation 
The qualitative and quantitative composition of soybean components is dramatically 
changed by physical and enzymatic processes during the preparation of soy-based foods 
(L.M. Baek et al., 2008; Garcia et al., 1997; Jang et al., 2008; Y.W. Lee et al., 2007; Nakajima et 
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al., 2005; J.S. Park et al., 1994; Yamabe et al., 2007). Fermentation is an excellent processing 
method for improving nutritional and functional properties of soybeans due to the 
increased content of small bioactive compounds. The conformation of soy protein (glycinin) 
is easily changed by heat (steaming) and salt (K.S. Kim et al., 2004). The large protein, lipid, 
and carbohydrate molecules in raw soybean are broken down by enzymatic hydrolysis 
during fermentation to small molecules such as peptides, amino acids, fatty acids, and 
sugars, which are responsible for the unique sensory and functional properties of the final 
products. Short-term fermented soy foods such as chungkukjang, which are fermented with 
B. subtilis, for less than 72 hr have a much greater concentration of large molecules than do 
long-term fermented foods including meju and doenjang, which are fermented for more 
than 6 months with Bacillus and Aspergilus species from rice straw and koji, respectively 
(Jang et al., 2008; Y.W. Lee et al., 2007; J.S. Park et al., 1994; Yamabe et al., 2007). Proteomic 
analysis for soluble proteins from chungkukjang at different fermentation periods suggested 
that most of the soluble soy proteins were degraded into smaller forms within 20 hr, and 
many microbial proteins, such as mucilage proteins which, are assimilated into the bacterial 
biomass, dominated by the soluble protein fraction. The proteomic profile of chungkukjang 
was very different from that of natto, in terms of the 2-D gel protein profile (Santos et al., 
2007) (Fig. 2).  
 
 
 
Fig. 2. A comparison of soluble proteins from chungkukjang and natto on a 2-D gel. Phenol 
extracted soluble proteins from chungkukjang (A) and natto (B) were separated on pH 4-7 
IPG strip and 12% SDS-PAGE gel (18×20 cm), and 50 randomly selected protein spots were 
analyzed by MALDI-TOF MS (Santos et al., 2007). 
The degradation of lipids and carbohydrates proceeds especially rapidly during the initial 
stage of fermentation, since these are used as the major energy sources for the 
microorganisms (Yamabe et al., 2007). After the initial stage of fermentation, however, soy 
proteins are rapidly degraded and only a small amount of the crude protein remains at the 
end stage of long-term fermentation. Soybean isoflavones appear to be the major 
components responsible for the bioactive functions such as lowering the risks of cancers of 
breast, prostate, and colon, cardiovascular diseases and osteoporosis.  
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Isoflavones, which are mostly present as 6-O-malonylglucoside and ǃ-glucoside conjugates 
and associated with proteins in soybean, are also broken down by heat treatment and 
fermentation (Barnes et al., 1998; H.K. Choi et al., 2007). During preparation of fermented 
soy foods, 6-O-malonylglucosides, the most prevalent soybean isoflavones, are converted to 
6-O-acetylglucosides or ǃ-glucosides by heating, and ǃ-glucosides are de-conjugated by the 
action of ǃ-glucosidases secreted by fermentation microorganisms (Murphy et al., 1999). 
Most isoflavones are not enzymatically hydrolyzed during short-term fermentation, in 
contrast to long-term fermentation in which 6-ο-malonylglucoside content declines with 
increasing fermentation time with concomitant increases in unconjugated aglycones 
(genistein and daizein). Total isoflavone content in raw soybeans was about 3,000mg/kg 
and this decreased by about 50% during cooking prior to chungkukjang preparation. Total 
isoflavone content of chungkukjang changed slightly during 45 hr fermentation. However, 
the content of isoflavone glycosides, consisting mainly of daizein, glycitin and genistin, 
decreased by about 40% during 45 hr fermentation, while the contents of free isoflavones 
including, daidzein, glycitein and genistein showed a dramatic increase during 
chungkukjang fermentation, with 2.9-, 54.0-, and 20.6 fold increases in concentration, 
respectively, by end of fermentation (45 hr) (Jang et al., 2006) (Table 1).  
 
Isoflavone Fermentation time (hr) 
raw 0 5 10 15 20 25 30 35 40 45 
Daidzin 99±311) 454±17 425±24 401±25 327±28 280±5 245±22 191±5 192±7 212±7 204±10 
Glycitin 45±15 101±5 101±5 87±6 77±6 60±6 65±26 69±4 34±5 41±4 35±4 
Genistin 184±50 548±22 568±19 513±30 476±32401±14 333±16 295±12 289±17 281±14 259±22 
M-Daidzin 1009±29 129±41 127±29 82±7 97±12 75±9 120±54 96±30 113±22 134±10 120±27 
M-Glycitin 157±2 10±5 3±0 12±5 63±5 144±3 217±1 220±0 225±7 244±5 231±1 
M-Genistin 1111±8 tr2) tr tr tr tr tr tr tr tr tr 
A-Daidzin 85±47 75±3 64±8 54±2 56±5 83±2 93±2 91±3 94±2 99±5 97±6 
A-Glycitin 101±174 10±2 7±1 5±4 11±5 29±12 44±7 50±10 46±9 38±12 33±12 
A-Genistin tr 43±3 47±3 37±3 35±3 45±0 38±5 41±6 39±5 31±6 27±5 
Total glycoside 2818 1370 1341 1191 1142 1117 1156 1020 1033 1079 1006 
Daidzein tr 33±6 50±8 36±2 69±6 79±2 82±2 107±3 112±5 102±6 114±7 
Glycitein tr 4±3 3±4 5±3 43±6 100±0 141±4 152±2 156±2 171±1 165±2 
Genistein 7±2 5±4 16±3 9±1 32±9 45±1 39±1 71±4 72±5 52±3 64±4 
Total aglycone 7 43 69 51 143 223 262 330 341 325 342 
Total isoflavones 2825 1413 1410 1242 1285 1340 1418 1350 1370 1404 1348 
1)Values are mean ± SD (n-3). 2)tr : trace. 
Table 1. Isoflavone contents (μg/g dry water) of chungkukjang collected at various 
fermentation times (Jang et al., 2006).  
We also investigated changes in isoflavone contents during the fermentation of meju and 
doenjang (Jang et al., 2008) (Table 2-3). Most of isoflavones in cooked and unfermented 
soybean existed as glycosides (Table 2), accounting for total isoflavones. While isoflavone 
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contents were not changed significantly during the first 10 days of meju fermentation, they 
were changed between the 10 and 90 day from the initiation of fermentation, suggesting that 
there was the rapid growth of microorganisms and they produced isoflavone-degrading 
enzymes during those periods.  
 
Isoflavone Raw Steamed Fermented period (day) 
10 20 40 90 
Daidzin 98±18 454±3 367±22 355±19 334±8 110±28 
Glycitin 94±51 104±16 93±18 77±37 67±23 13±20 
Genistin 148±21 913±11 637±62 623±21 488±9 229±33 
M-Daidzin 1,080±44 61±3 280±31 165±14 196±6 92±41 
M-Glycitin 233±24 1±1 5±9 12±1 3±5 10±9 
M-Genistin 1,244±39 74±17 264±10 Tr1) Tr Tr 
A-Daidzin 23±16 55±5 50±8 47±0 46±8 14±1 
A-Glycitin 134±19 26±19 82±8 13±2 11±8 6±2 
A-Genistin 57±10 139±3 53±22 45±19 35±17 15±24 
Total glycosides 3,111±177 1,827±20 1,830±125 1,337±52 1,181±71 487±220 
Daidzein Tr Tr Tr 74±3 68±9 152±19 
Glycitein 13±7 6±1 Tr Tr 4±5 7±2 
Genistein 12±2 16±1 6±3 35±3 25±3 170±20 
Total aglycones 25±6 22±2 6±4 108±6 97±9 329±56 
Total isoflavones 3,137±174 1,849±23 1,836±123 1,445±47 1,278±65 816±276 
 1.)Trace 
Table 2. Change in isoflavone contents (μg/g) during meju fermentation (Jang et al., 2008)  
 
Isoflavone Aging period (day) 
0 20 40 60 80 120 140 160 
Daidzin Tr1) Tr Tr Tr Tr Tr Tr Tr 
Glycitin Tr Tr Tr Tr Tr Tr Tr Tr 
Genistin Tr Tr Tr Tr Tr Tr Tr Tr 
M-Daidzin Tr Tr Tr Tr Tr Tr Tr Tr 
M-Glycitin Tr Tr Tr Tr Tr Tr Tr Tr 
M-Genistin Tr Tr Tr Tr Tr Tr Tr Tr 
A-Daidzin Tr Tr Tr Tr Tr Tr Tr Tr 
A-Glycitin Tr Tr Tr Tr Tr Tr Tr Tr 
A-Genistin 27±5 36±7 32±5 42±7 41±8 42±17 29±8 16±2 
Total glycosides 27±5 36±8 32±6 42±8 41±9 42±18 29±9 16±3 
Daidzein 222±34 246±67 226±23 282±23 271±50 275±47 325±55 273±24 
Glycitein 72±14 78±21 72±4 82±5 82±17 71±16 89±22 79±23 
Genistein 298±27 366±81 349±42 411±25 361±40 374±36 334±1 292±55 
Total aglycones 592±70 689±167 646±64 775±50 714±106 719±75 749±110 644±14 
Total isoflavones 618±75 724±175 678±69 817±56 754±114 761±92 778±111 660±12 
1)Trace 
Table 3. Change in isoflavone contents (μg/g) during aging of doenjang (Jang et al., 2008)  
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The concentration of aglycones in meju was increased to reach to approximately 40% of total 
isoflavones in 90 day meju fermentation. However, during the aging step of doenjang 
production, no significant changes in isoflavone content were observed probably due to 
inhibition of microorganism growth under high salt condition (Table 3). 
In addition to the natural isoflavones found in soybeans, novel isoflavonoids such as equol 
(7-hydroxyisoflavan), dihydrodaidzein, and O-desmethylangolensin (Joannou et al., 1995; 
Lampe, 2009), known to be produced by intestinal microflora from daidzein, were found in 
some fermented soy products, which were metabolized by microorganisms (Fig. 3). Equol 
exhibits a more powerful estrogenic activity than daidzein and has been reported to exert 
beneficial health effects on various types of diseases such as osteoporosis, cardiovascular 
disease, hormone-dependent cancer, and post-menopausal syndrome. Therefore, equol 
production is probably one factor responsible for the decreased risk of certain cancers and 
other diseases in humans consuming fermented soybean foods. In general, the chemical 
profiles of various minor components related to health benefits and nutritional quality of 
products are also affected by fermentation (Izumi et al., 2000; D.J. Kim et al., 2008) 
Among the various small metabolites derived from macromolecules, the changes in amino 
acid and peptide concentrations were especially prominent, although qualitative and 
quantitative changes in individual peptides were not studied. Some amino acids increased 
and others remained almost constant with increased fermentation time, but glutamate, the 
richest amino acid in soybean, was obviously decreased by fermentation, suggesting that 
microorganisms might use it as a preferred nitrogen source (Kada et al., 2008). Novel 
bioactive oligopeptides from soybean protein which are produced by fermentative 
microorganism is an emerging area of research with great promise. It is well known that 
various tastes and flavors such as umami, bitter taste and savory flavor originate from 
soybean peptides.  
 
 
Fig. 3. Metabolism of the soy isoflavone daidzein to O-desmethylangolensin and equol. 
Adapted from Heinonen et al. (1999). 
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 S.H. Kim & Lee (2003) evaluated the flavor compounds in water-soluble extract from 
doenjang by fractionating the amino acids and peptides by gel filtration chromatography 
(Table 4). Umami taste in doenjang and the savory flavor of fermented and non-fermented 
soy foods, such as soy sauce and hydrolyzed vegetable protein, are the result of the release 
of small peptides and amino acids from the fermentative digestion or acidic hydrolysis of 
soy proteins (Aaslyng et al., 1998; Rhyu & Kim, 2011).  
In addition to the umami taste, soy protein is reported to have numerous beneficial effects in 
humans, including improvements in body composition, anti-hypertension, insulin secretion 
etc. (S.J. Kim et al., 1999; Sites et al., 2007). Many peptides having anti-hypertension and 
hypocholesterolemic from doenjang and kanjang have been isolated. Detailed structure of 
bioactive peptides preventing hypertension and hypercholesterolemia will be described in 
section 7.1. 
 
Amino acids Fractions Threshold Tastes of 
(mg/l) (Vt, 
ml)a 
2 3 4 5 6 7 value (mg/l)b free amino acid in 
waterb 
Asp (Na) 0 0 24 36 4 2 1000 Umami 
Ser 1 2 2 61 13 2 1500 Sweet 
Glu (Na) 1 0 150 65 10 2 300 Umami 
Gly 1 0 5 16 4 1 1300 Sweet 
His 1 0 2 27 3 1 200 Bitter 
Thr 1 1 4 67 12 0 2600 Sweet 
Arg 1 1 2 19 14 0 500 Bitter 
Ala 1 1 4 120 13 0 600 Sweet 
Pro 0 2 9 98 8 2 3000 Sweet, Bitter 
Cys 0 18 150 18 0 5 ndc Bitter 
Tyr 0 3 11 2 2 50 nd Bitter 
Val 0 1 6 82 9 0 400 Bitter 
Met 1 3 4 0 6 0 300 Sweet 
Lys 1 3 82 27 6 2 500 Bitter 
Ile 1 2 9 70 11 1 900 Bitter 
Leu 1 1 3 120 18 2 1900 Bitter 
Phe 0 1 1 1 22 25 900 Bitter 
Total 11 39 468 829 155 95   
aVt = Total volume of the fractions obtained after chromatography of 10 ml water-soluble extract. 
bdefined as in Kato et al. (1989). 
c not detected. 
Table 4. Concentration of free amino acids identified in each tasted Sephadex G-25 gel 
filtrate obtained from the water-extract of doenjang (S.H. Kim & Lee, 2003). 
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5. Metabolite profiling of fermented soybean foods 
Thousands of metabolites are among the fermented products produced by microorganism 
during fermentation. Most of metabolites such as fatty acids, organic acids, amino acids, 
peptides or isoflavone derivatives as described above are produced from the soybean by 
degradation, however, some metabolites do not originate from soybean. This means that 
fermenting microorganisms, especially Aspergillus species, might produce new metabolites 
by themselves, using soybean as a substrate source in the long fermentation period.  
Chungkukjang has a characteristic flavor which is generally acceptable to Koreans but 
hardly tolerable to some foreign people. Volatile organic acids, such as acetic acid, propionic 
acid, 2-methylpropanoic acid, butanoic acid and 3-methylbutanoic acid, have been identified 
as the characteristic flavor in chungkukjang by gas chromatography-mass spectrometry 
(GC-MS) (M.K. Park et al., 2007). The contents of volatile organic acids in chungkukjang 
were highly dependent on the fermentation period; increasing during fermentation. 
Moreover, the branched-chain organic acids (2-methypropionic acid and 3-methylbutanoic 
acid) were formed earlier and were present in much higher concentration than the 
corresponding straight-chain organic acids during chungkukjang fermentation. We 
investigated which metabolites were made from different chungkukjang in terms of 
fermentation time and inoculated strains, B. subtilis, B. amyloliquefaeciens and B. licheniformis 
by GC-MS: the metabolite profiling of chungkukjang by PCA (principal component 
analysis) and PLS-DA (partial least square discriminant analysis) showed that some sugars 
and organic acids including sucrose, fructose, glucose, mannose, succinic acid, and malonic 
acid, as well as most amino acids, contributed mainly to differentiation of the different 
chungkukjangs according to fermentation time. The levels of most amino acids decreased in 
the early stage of fermentation and in increased in the late stage of chungkukjang 
fermentation with B. subtilis (M.K. Park et al., 2010). The levels of fatty acids generally 
increased throughout the fermentation process and levels of most organic acids, except for 
tartaric acids, decreased. Tryptophan, citric acid, ǃ-alanine, itaconic acid, 2-hydroxyglutaric 
acid, Ǆ-aminobutyric acid, leucine, malic acid, and tartaric acid were the major components 
that discriminated various chungkukjangs according to fermentation period. On the other 
hand, mannose, xylose, glutamic acid and proline were mainly responsible for 
differentiating the chungkukjang according to the various inoculated strains (Baek et al., 
2010).  
In addition to metabolic profiling by GC-MC analysis, metabolomic profiling of 
chungkukjang during fermentation was also carried by 1H NMR spectrometry and PCA. 
The major peaks in the 1H NMR spectra of the 50% methanol fraction of chungkukjang 
corresponded with isoleucine/leucine, lactate, alanine, acetic acid, citric acid, choline, 
fructose, sucrose, tyrosine, phenylalanine and formic acid (H.K. Choi et al., 2007) (Fig. 4).  
The first two principle components (PC1 and PC2) of the 1H NMR spectra of the aqueous 
fraction (Fig. 5) allowing discrimination of chungkukjang extracts obtained after different 
periods of fermentation showed that samples obtained after 0 hr and 5 hr of fermentation were 
separated but relatively close proximity to each other. Similarly, score plots of the samples 
obtained after 10, 20, and 40 hr of fermentation were separated clearly from each other. The 
spectra for samples obtained during the later stages of fermentation (20-40 hr) were less 
pronounced than those that occurred in samples obtained earlier. Therefore, fermentation 
appeared to occur primarily between 5 and 20 hr after the start of the fermentation process. 
The major compounds that contributed to discrimination were isoleucine/leucine, lactate, 
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acetic acid, citric acid, choline, fructose, tyrosine and phenylalanine. Among them, lactate, 
acetic acid, citric acid, fructose and sucrose contributed mainly to discrimination by PC1, while 
lactate, acetic acid, citric acid, choline, sucrose, tyrosine and phenylalanine contributed mainly 
to discrimination by PC2. The GC-MC and NMR results revealed similar metabolic profiling of 
chungkukjang according to fermentation periods. 
 
 
Fig. 4. Representative 1H nuclear magnetic resonance (NMR) spectra of the total (a) and 
aromatic (b) region of the aqueous fraction of chungkukjang extracts from samples obtained 
at the start of fermentation. IS, internal standard; 1, isoleucine/leucine; 2, lactate; 3, alanine; 
4, acetic acid; 5, citric acid; 6, choline; 7, fructose; 8, sucrose; 9, tyrosine; 10, phenylalanine; 
11, formic acid; w, water. Values on the X-axis are the chemical shift in ppm relative to TSP 
(H.K. Choi et al., 2007).  
 
 
Fig. 5. Principal component analysis (PCA)-derived score plot of the first two principal 
components (PC1 and PC2) of the aqueous fraction of chungkukjang extracts. (H.K. Choi et 
al., 2007). 
Metabolomic analysis of meju during fermentation by ultra performance liquid 
chromatography-quadrupole-time of flight mass spectrometry (UPLC-Q-TOF MS) revealed 
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that various metabolites, including amino acids, small peptides, nucleosides, urea cycle 
intermediates, and organic acids, responsible for the unique taste and nutritional and 
functional quality of fermented soy foods, were clearly altered by increasing the 
fermentation period (Kang et al., 2011). Changes in these metabolites allowed discrimination 
among meju samples with different fermentation periods (0, 10, 20, 40, and 60 day) on a 
PLS-DA score plot, and the fermentation was mainly processed between 10 and 40 day of 
fermentation. Twenty-two metabolites (phenylalanine, glutamic acid, leucine, adenine, 
citrulline, arginine, glutamine, Ȣ-aminobutyric acid, proline, acetylornithine, valine, 
pipecolic acid, methionine, citric acid, xanthine, tyrosine, isoleucine, Glu-Tyr, Ser-Pro, 
tryptophan, Glu-Phe, and Leu-Val-Pro-Pro) with high PLS-DA values over 1.00 were 
determined to be the major compounds contributing to the discrimination of meju samples. 
These metabolites, which were positively related to the sensory quality of meju, can be used 
as fermentation biomarkers for the production of meju and construction of the meju 
fermentation metabolic pathway. Based on the metabolites found, we constructed a meju 
fermentation metabolic pathway that shows the overproduction and underproduction of 
metabolites during fermentation and the several related cycles, including the urea cycle, 
TCA cycle, glutamine cycle, and methionine cycle (Kang et al., 2011) (Fig. 6).  
 
 
 
Fig. 6. Schematic representation of metabolites produced during meju fermentation. 
Metabolites identified by UPLS-Q-TOF are marked with black and grey. Black, grey, and 
open circles represent increased, decreased, and undetected metabolites, respectively. Most 
metabolites were physically and enzymatically produced from soybean biomass during 
fermentation, but some metabolites might originate from the biomass of microorganisms 
(Kang et al., 2011). 
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Some microbial metabolites being independent of proteins and other large molecules from 
soybean were produced by the proposed pathway during meju processing. Some 
metabolites, such as citrulline, for example, were likely produced via some part(s) of the 
pathways.  
The metabolomic profiling of doenjang by NMR-PCA and GC-MS (Namgung et al., 2010; 
S.O. Yang et al., 2009) demonstrated that the predominantly produced amino acids included 
alanine, valine, leucine, isoleucine, proline, glutamine, phenylalanine and lysine, showing 
remarkable increases in amounts during the later stages of fermentation. Carbonic acid, 
citric acid, lactic acid and pyrogultamic acid were identified as the major organic acids. 
Significant amounts of erythrose, xylitol, inositol and mannitol were also detected during 
fermentation. Among fatty acids, relatively higher amounts of palmitic acid, stearic acid, 
oleic acid, linoleic acid and linolenic acid were found in the doenjang at each fermentation 
time point. Our results indicate that monitoring the changes in metabolites during meju 
fermentation might be important for producing meju-related foods (doenjang and kanjang) 
with good nutritional and sensory quality. 
The study of metabolomics plays a crucial role in determining the changes in metabolites in 
fermented foods but also detecting bioavailability of metabolites after the consumption of 
foods. The function of soybeans and fermented soybeans in humans are somewhat different 
possibly due to their different metabolite in the blood. Thus, it is necessary to study 
bioavailability of metabolites in the blood using metabolomics methods in humans after 
consuming soybean products.  
6. Functionality of soybean products 
6.1 Soybeans 
Soybeans are well known for their health-promoting benefits which include antioxidation, 
anti-obesity, anti-diabetes, properties and prevention of osteoporosis and cancers such as 
breast and prostate cancer (Anderson et al., 2008; Anderson & Pasupuleti, 2008; Messina et 
al., 1999). Many studies, but insufficient and inconclusive, suggest that these kinds of health 
function are primarily due to esterogenic properties of isoflavones but the results are still 
controversial (Kwon et al., 2010). There are hundreds of in vitro studies showing that 
genistein has anti-oxidant properties, inhibits the growth of a wide range of both hormone-
dependent and hormone independent cancer cells, including breast (Pagliacci et al., 1994; 
Peterson et al., 1996; Zava & Duwe, 1997), prostate (Kyle et al., 1997; Zhou et al., 1999), colon 
(Kuo, 1996; Kuo et al., 1997), and skin (Rauth et al., 1997) cells (Adlercreutz & Mazur, 1997; 
Akiyama & Ogawara, 1991; Constantinou & Huberman, 1995) and that genistein also 
inhibits the metastatic activity of both breast (Peterson & Barnes, 1996; Scholar & Toewa, 
1994) and prostate (Santibáñez et al., 1997) cancer cells independent of the effects on cell 
growth. Daidzein, one of the 2 primary isoflavones in soybeans, exhibits anticancer effects 
(Jing et al., 1993). Recently, genistein was also demonstrates to have anti-inflammatory 
properties (Hernandez-Montes et al., 2006; Verdrengh et al., 2003), and we found that 
genistein decreased cisplatin induced apoptosis by regulation p53 induction in kidney, and 
reactive oxygen species production in cisplatin-treated normal kidney HK-2 cells (Sung et 
al., 2008). Our previous review (Kwon et al., 2010) described in detail the anti-obesity effects 
of soybean for type 2 diabetes. Some studies of the effects of soybeans, including 
isoflavonoids and soy proteins, on glucose metabolism are inconsistent, and the 
mechanisms have not been extensively studied. However, other studies showed positive 
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effects on hypocholesterolemia, for example, 46 postmenopausal women taking isolated 
isoflavone extracts had significantly increased high-density lipoprotein cholesterol and a 
decrease in apolipoprotein B, the primary apolipoprotein in low-density lipoprotein 
particles (Clifton-Bligh et al., 2001; Goodman-Gruen & Kritz-Silverstein, 2001).  
In soy protein nutrition, the sulfur amino acids, methionine and cysteine, are the limiting 
amino acids. However, the relatively low sulfur amino acid content of soybeans may 
actually provide an advantage in terms of calcium retention ironically. The reported 
hypercalciuric effect of protein is likely to be at least partially due to the metabolism of 
sulfur amino acids. The skeletal system serves as one of the main buffering systems in the 
body; as a result, the hydrogen ions produced from the metabolism of sulfur amino acids 
cause demineralization of bone and excretion of calcium in the urine (Remer & Manz, 2001). 
Thus, bean protein may improve calcium retention relative to animal and grain proteins.  
Soy protein also has a cholesterol lowering effect in monkey (Terpstra et al., 1984) and in 
men (Wong et al., 1998), and protein hydrolyzate or hydrolyzed peptides of soybeans 
decrease blood cholesterol and glucose levels (Kwon et al., 2002; Yoshikawa et al., 1999). 
Lunasin, a 43-amino-acid peptide from soy, has been shown to have numerous biologic 
properties including anticancer and anti-inflammatory activities (Galvez et al., 2001; Mejia & 
Dia, 2009; K.Y. Park et al., 2001). In fact, we identified hypocholesterolemic peptides from 
fermented soy products, including doenjang (see following section), and soy protein isolates 
are known to activate peroxisome-proliferator–activated receptors (PPARs) and liver X 
receptor signaling and to inhibit sterol regulatory element-binding protein-1c signaling, 
contributing to insulin sensitization (Jhala et al., 2003; Ronis et al., 2009)]. In addition, soy-
fed CD-1 mice exhibited enhanced insulin sensitivity, especially in white adipose tissue, due 
to the potentiation of phosphorylation of AMP-activated protein kinase and acetyl-CoA 
carboxylase and up-regulation of the expression of genes involved in peroxisomal fatty acid 
oxidation and mitochondrial biogenesis and in skeletal muscles by increasing glucose 
uptake (Cederroth et al., 2008).  
It is also well-known that substituting vegetable oils, such as soybean oil, for animal fat 
reduces the risk of high blood pressure, thrombosis, platelet generation, and cholesterol 
accumulation (Meydani et al., 1991). Soybean oils contain health promoting linoleic, 
linolenic acids, and phytochemicals.   
6.2 Chungkukjang 
Recently, there has been growing interest in chungkukjang due to its effects on health. 
Previous reports indicate that the consumption of chungkukjang decreases blood pressure 
and serum lipids (J.L. Yang et al., 2003). In addition, dietary supplementation with 
chungkukjang exerted not only hypoglycemic effects but also antioxidant effects in diabetic 
rats (Kwon et al., 2007a). After fermentation, isoflavonoid glycones are changed into 
isoflavonoid aglycones, which seem to have greater anti-diabetic activity than do 
isoflavonoid glycones (Table 1, 2, 3) (Jang et al., 2006). Kawakami et al. (2005) demonstrated 
that an isoflavone aglycone–rich diet reduced liver and serum total cholesterol levels, and 
liver triglyceride levels in rats fed cholesterol. Thus, fermented soybean products may be 
more effective for ameliorating metabolic disorders due to increased isoflavonoid aglycone 
content. 
We demonstrated that the ethanol extract of chungkukjang inhibits the generation of 1,1-
diphenyl-2-picryl hydrazine (DPPH) radicals and prevents LDL oxidation. Chungkukjang 
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and its constituents (genistein and daidzein) also inhibited H2O2-induced DNA damage 
from NIH/3T3 fibroblasts and exhibited cytoprotective effects against H2O2-induced cell 
death. An in vivo study also demonstrated that an oral administration of chungkukjang 
water extract potently inhibited the formation of malondialdehyde, DNA damage and the 
formation of micronucleated reticulocytes in KBrO3-treated mice (N.Y. Kim et al., 2008); 
ethanol extract of chungkukjang showed anti-inflammation activity by inhibiting 5-
lipoxygenase from A23187-treated RBL-1 cells, and reducing leukoriene production (Y.H. 
Choi et al., 2008). Chungkukjang significantly reduced passive cutaneous anaphylaxis in rats 
at 400 mg/kg/day and also showed in vivo anti-inflammatory activity against arachidonic 
acid-induced mouse ear edema. We found that the methanol extract of 40 hr fermented 
chungkukjang exhibited the highest degrees of free-radical-scavenging and tyrosinase-
inhibition activities, which have been indicated to prevent hyperpigmentation. These results 
suggest that chungkukjang extracts possess antioxidative anti-inflammatory and tyrosinase-
inhibition activities, which are attributable to phenolics other than flavonoids (H.K. Choi et 
al., 2008). 
Anti-diabetic effect was intensively studied with colleagues (D.J. Kim, 2008; Kwon et al., 
2006, 2007a, 2007b); several animal studies and a few human studies have evaluated the 
effects of fermented soybeans on glucose metabolism as reviewed previously (Kwon et al., 
2010). We found that chungkukjang improves glucose homeostasis by enhancing hepatic 
insulin sensitivity and insulinotropic actions in 90% pancreatectomized rats, a type 2 
diabetic animal model (Kwon et al., 2007a, 2007b). In addition, chungkukjang enhanced 
glucose-stimulated insulin secretion in a hyperglycemic clamp study in diabetic rats and 
increased pancreatic ǃ-cell mass via increased proliferation and decreased apoptosis. D.J.  
Kim et al. (2008) also showed similar results in C57BL/KsJ-db/db mice. Chungkukjang 
supplementation induced a significant decrease in blood glucose and glycosylated 
hemoglobin levels and improved insulin tolerance compared to the diabetic control group 
via increasing serum insulin and pancreatic insulin contents. Therefore, chungkukjang 
delayed diabetic symptoms in type 2 diabetic rats more than non-fermented soybeans, and 
this was related to increased isoflavonoid aglycones such as daidzein and genistein and 
small peptides.  
In addition to anti-diabetic effects of chungkukjang, there is epidemiological evidence that 
chungkukjang has anti-obesity effects, but insufficient data exist. It is known that soybean 
and soy components have an anti-obesity and anti-diabetes (Anderson & Pasupuleti, 2008), 
however, the active compounds from fermented soybeans for obesity and diabetes are not 
fully identified. The hydrolyzated/fermented peptides or other phytochemicals produced 
during fermentation will be potential candidates for these actions. Although certain types of 
peptides isolated from the breakdown of soybeans or fermented by microbes have shown 
antihypertensive and anti-inflammatory properties (Inoue et al., 2009; Kato et al., 1989; S.H. 
Kim et al., 1999; Mejia & Dia, 2009), no specific peptides have revealed anti-obesity and anti-
diabetic actions due to the difficulties of isolation and identification of bioactive compounds 
such as peptides.  
We tried to identify the anti-obesity effects of chungkukjang by analyzing the hepatic 
mRNA expressions of enzymes related to fatty oxidation by RT-PCR analysis in high fat-fed 
mice (Soh et al., 2008). The expression of hepatic ACS (acyl-CoA synthase), CTP-1 (carnitine 
palmitoyltransferase-1), ACO (acyl-CoA oxidase), and UCP2(uncoupling protein-2) were 
increased by chungkukjang supplementation. The data demonstrated that chungkukjang 
supplementation leads to increased mRNA expressions of enzymes and protein involved in 
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fatty acid oxidation in liver, reduced accumulation of body fat and improvement of serum 
lipids in high fat diet fed mice (Kwon et al., 2007a; Soh et al., 2008). In addition, the hepatic 
transcriptional profiles using cDNA microarray showed that several genes involved in fatty 
acid catabolism (Acaa2, Mgll, Phyh, Slc27a2, Slc27a5), which were the main genes that had 
altered expressions by high fat diet, were normalized by chungkukjang consumption (Table 
5) (Soh et al., 2011). Gene expression profiles obtained by both microarray and RT-PCR 
analysis were very similar with regard to the direction (up- or down-regulation) and degree 
of differences in expression. The result means that chungkukjang consumption improves 
serum lipid profiles and body fat accumulation, probably by modulating transcriptional 
levels of enzymes for utilization of fatty acids. 
 
Genbank 
No 
Gene cDNA microarray Real time RT-
PCR 
HDcon HDC HDcon HDC 
BG085346 Acetyl-Coenzyme A acyltransferase 2 
(Acaa2) 
-4.18 ↔1) 0.282) 0.94 
A277495 Carnitine palmitoyltransferase 1a, liver 
(Cpt1a) 
ND3) ND 1.73 3.41 
BF457090 24-dehydrocholesterol reductase (Dhcr24) 2.1 ↔ 1.45 0.78 
BG063933 Dolichyl-phosphate (UDP-N-
acetylglucosamine) 
acetylglucosaminephosphotransferase 1 
(Dpagt1) 
2.3 ↔ 3.02 1.91 
AA023077 Hydroxysteroid 11-beta dehydrogenase 1 
(Hsd11b1) 
-8.95 ↔ 0.23 1.14 
AI835105 Monoglyceride lipase (Mgll) -8.99 ↔ 0.29 0.62 
W82212 Phytanoyl-CoA hydroxylase (Phyh) -5.78 ↔ 0.37 1.21 
AI893897 Paraoxonase 1 (Pon1) 2.0 ↔ 1.68 0.69 
AA259329 Protein kinase, AMP-activated, gamma 1 
non-catalytic subunit (Prkag1) 
2.2 ↔ 2.20 1.41 
AA108401 Solute carrier family 27 (fatty acid 
transporter),  
member 2 (Slc27a2) 
-4.06 ↔ 0.25 0.86 
AA254935 Solute carrier family 27 (fatty acid 
transporter),  
member 5 (Slc27a5) 
-11.73 ↔ 0.25 0.83 
1)The double headed arrow symbol () denotes that there is no significant difference when gene 
expression in HDcon (high fat diet control) or HDC (high fat diet with chungkukjang) groups were 
compared with the NDcon (normal diet control) group. 2)Data are expressed as fold changes, 
normalized to ǃ-actin mRNA expression, where the values for the NDcon mice were set at 1.00. The 
analyses were performed in duplicate. 3)ND, not detected. (Soh et al., 2011) 
Table 5. A comparison between cDNA microarray analysis and real time RT-PCR (3-12).  
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6.3 Meju and doenjang 
It is known from in vitro studies that doenjang has various beneficial properties, such as 
anticancer, antimetastatic, antihypertensive and antimutagenic activities (Jung et al., 2006; 
K.Y. Park et al., 2003; S.O. Yang et al., 2009) reported doenjang showed higher 
antimutagenic activity than raw soybeans, cooked soybeans, and other fermented soybeans 
in the Ames test (A.E. Burtler et al., 2003). The active compounds that were identified 
included genistein, linoleic acid, ǃ-sitosterol glucoside, soya saponin, etc. Anticancer and 
antimetastatic properties of doenjang were enhanced as aging time progressed (see Fig. 1) 
(Jung et al., 2006). The 24 month fermentation was the most effective in preventing cancer by 
decreasing tumor formation and increasing natural killer cell activity in spleens and 
glutathione S-transferase activity in livers of mice. Unlike chungkookjang, doenjang has not 
been demonstrated to affect glucose homeostasis because sample preparation is very 
difficult for studying anti-diabetic effects due to the high content of salt. However, some 
compounds from doenjang have been shown to have greater activity for reducing blood 
pressure in terms of angiotensin converting enzyme (ACE) inhibition (Hwang, 1997; S.H. 
Kim et al., 1999). 
The health effects of meju have not attracted much research interest because meju is not the 
food that is eaten directly. Recently, however, interest in its functional properties has 
increased gradually because of its impact on functionality when making doenjang and 
kanjang. Like as doenjang, ACE inhibitory factors associated with its peptides were found in 
solid meju extract which was fermented with B. subtilis (Hwang, 1997). In addition, Min6 
insulinoma cells treated with genistein, chungkukjang or meju extract (60 day fermentation) 
had greater glucose-stimulated insulin secretion capacity and greater ǃ-cell viability than 
those treated with unfermented soybeans (Kwon et al., 2011b). This improvement was 
associated with the activation of insulin/insulin-like growth factor-1 signaling; the tyrosine 
phosphorylation of insulin receptor substrate-2 and serine phosphorylation of Akt was 
potentiated, and this in turn increased the expression of pancreatic and duodenal 
homeobox-1 involved in ǃ-cell proliferation. Furthermore, genistein, daidzein, and meju 
extract stimulated glucagon-like peptide-1 secretion in enteroendocrine NCI-H716 cells, 
which generated insulinotropic actions, meaning that meju has a better anti-diabetic action 
than soybeans soybeans (Kwon et al., 2011b).  
6.4 Kochujang 
Kochujang containing meju and red pepper may affect energy, lipid, and glucose 
metabolism. Current investigations are concentrating their efforts on investigating the 
biological and physiological functions of kochujang because red pepper, a major component 
of kochujang, and its active principle capsaicin are known to enhance energy and lipid 
metabolism, possibly by increasing catecholamine secretion from the adrenal medulla 
through the activation of the sympathetic nervous system (Diepvens et al., 2007; Karlsson, 
1994). In fact, several studies have indicated that traditional kochujang exhibits anti-
mutagenic activity (S.J. Kim et al., 1999), and antitumor effects (K.Y. Park et al., 2001) are 
reported. Anti-obesity effects were reported in mice and rats fed with high fat diets 
(Ashiuchi et al., 2001; Choo, 2000; Koo et al., 2008); fermented kochujang supplementation of 
a high fat diet prevented obesity in mice by reducing fat deposition and decreased 
circulating levels of cholesterol, triglycerides, and blood glucose, mediated by down-
regulating expression of lipogenic enzymes and up-regulating the lipolytic enzymes and the 
thermogenesis gene UCP-1 (Koo et al., 2008).  
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The decreased numbers of adipocytes by lipolysis may improve glucose tolerance by the 
enhancing insulin sensitivity. Although capsaicin content in red pepper was reduced by 
approximately 50% during the fermentation process, kochujang has been shown to reduce 
body weight, visceral fat, and serum leptin levels without modulating energy intake in 
diabetic rats (Kwon et al., 2009). It also improves glucose tolerance by enhancing insulin 
sensitivity. The improvement in hepatic insulin sensitivity lowered hepatic glucose output 
and triglyceride accumulation and increased glycogen storage. The possible mechanism is 
the potentiated phosphorylation of signal transducer and activator of transcription-3 → 
AMP-activated protein kinase → acetyl CoA carboxylase and the reduced the expression of 
phosphoenolpyruvate carboxykinase, a regulatory enzyme for gluconeogenesis, in the liver 
(Choi & Suh, 2004).  
7. Bioactive soypeptides and design of new peptides  
Many oligopeptides produced from soy protein by digestive endogenous or microbial 
proteinase during fermentation, demonstrated a range of biological activities – angiotensin 
converting enzyme (ACE) inhibition, anti-thrombotic, surface tension and antioxidant 
properties (Gibbs et al., 2004). The biologically active peptides were mostly derived from 
glycinin, a highly expressed soy protein, therefore some researchers investigated the novel 
bioactive peptides isolated from soyprotein by treatment with endoproteinase (pronase, 
trypsin, pepsin, Glu C protease, plasma proteases and kidney membrane proteases). 
Bioactive peptides were isolated from the fermented soybean products by Bacillus species or 
Aspergillus species and identified the structures. We also isolated ACE inhibitory peptides, 
antithrombotic and hypocholesterolemic peptides and identified the structures from 
doenjang (S.H. Kim et al., 1999; Kwon et al., 2002).  
7.1 Bioactive peptides 
A Chinese group tried to isolate the ACE inhibitory peptides from soy protein by treating it 
with protease and testing the fraction for hypotensive effects in SHR (spontaneous 
hypertensive rats) (Wu & Ding, 2001; Gouda et al. 2006) also isolated active fraction from 
soyprotein peptides hydrolyzed by protease P and its sequential structure was identified as 
Val-Leu-Ile-Val-Pro (VLIVP). The sequence of VLIVP corresponded to Val397-Pro401 of the 
glycinin subunit G2 of soybean. From kidney bean protein hydrolyzate, ACE inhibitory 
peptide was isolated and identified as Val-Ile-Pro-Ala-Ala-Tyr (VIPAAY) (J.R. Lee et al., 1999).  
Fermented soy peptides from doenjang (S.H. Kim et al., 1999) and miso (Inoue et al., 2009) 
have also been shown to possess ACE inhibitory activity in vitro and a dipeptide (Ala-Pro, 
AP) and tripeptides (Val-Pro-Pro, VPP and Ile-Pro-Pro, IPP) from doenjang and miso are 
reported to act as antihypertensive agents in SHR. The primary structural and configuration 
properties of ACE inhibitory peptides from soybean were similar; it starts with an alipathic 
nonpolar amino acid group such as Val, Ala, and Ile at the N-terminal and ends with Pro at 
the C-terminus (S.H. Kim et al., 1999). A certain in ACE inhibitory peptide, His-His-Leu 
(HHL) isolated from doenjang (Shin et al., 1995), exerts a significant decrease of ACE 
activity in the aorta and leads to lowered systolic blood pressure (SBP) in SHR (Shin et al., 
2001). After determining the sequence of these peptides, efficacy studies were done by 
synthesizing the authentic and analogue peptides and the mechanism was also elucidated 
(Gouda et al., 2006; Shin et al., 2001). It was not determined which of the peptides in kanjang 
had ACE inhibitory, anti-thrombotic or antioxidant properties, however, a couple of papers 
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on the ACE inhibition activity of peptides and nicotinamide in Japanese soy sauce or soy 
seasoning were reported (Kinoshita et al., 1993; Makahara et al., 2010; Zhu et al., 2008). 
Based on the studies that observed hypocholesterolemic effects of soybean protein in 
humans and monkeys (Terpstra et al., 1984; Wong et al., 1998), hypocholesterolemic 
peptides were isolated from glycinin hydrolyzate by trypsin and pepsin digestion. The 
identified primary structure was Leu-Pro-Tyr-Pro (LPYP) (Kwon et al., 2002) and Ile-Ala-
Val-Pro-Gly-Glu-Val-Ala (IAVPGEVA) and Ile-Ala-Val-Pro-Thr-Gly-Val-Ala (IAVPTGVA) 
(Pak et al., 2004, 2005c) from glycinin hydrolyzed by trypsin and pepsin, respectively. 
Hypocholesterolemic activity was determined by assaying the inhibition of 3-hydroxcy-3-
methylglutaryl CoA reductase (HMG-CoA reductase) in vitro and by determining the serum 
cholesterol levels in mice. The sequence (LPYP) was very similar to Yoshigawa’s peptide 
(LPYPR) (Yoshikawa et al., 1999) also isolated from glycinin hydrolyzate, and the sequences 
including SPYPR correspond to the A5A4B3 and A3B4 regions of glycinin (Fukazawa et al., 
1985; Momma et al., 1985). LPYPR was a little better HMG CoA reductase inhibitor than 
LPYP in vitro, but both reduced serum cholesterol levels by the same amount (30%) (Kwon 
et al., 2002). Our results indicate a positive correlation between the binding of cholic and 
deoxycholic acids and the hypocholesterolemic effects of the pepsin hydrolyzate peptide 
(IAVPGEVA), while peptide hydrolyzates from trypsin digestion (LPYP and LPYPR) had 
hypocholesterolemic effects and gave a negative correlation for binding of bile acids. 
Therefore, the degree of interaction of bile acids is not ssential for identifying 
hypocholesterolemic activity (Pak et al., 2005a, 2005b).  
7.1.1 Mode of actions of isolated peptides 
Design of more potent compounds based on known bioactive compounds in terms of 
structure and mode of action is one of the best way to reduce the risks of failure and to save 
time and expense in the development of bioactive compounds. Using the peptides 
previously identified, therefore, we tried to design more powerful HMG CoA reductase 
inhibitors from soy peptide and compared them to statins and statin derivatives. Statins are 
known inhibitors that effectively lower plasma cholesterol levels. All statins have a chemical 
structure similar to HMG in their molecules (Istvan, 2003; Istvan & Deisenhofer, 2000a, 
2000b; Wilding et al., 2000).  
In general, understanding the relationship between structure and activity (mode of action) 
for two peptide structures, namely LPYP and IAVP are essential for a new peptide design. 
In cholesterol synthesis, isoprenoids comprise a large group of natural compounds that are 
formed in living cells from mevalonic acid and are involved in various cellular functions 
such as growth regulation of higher plants, fungi, and mammals, including sterol synthesis 
(Bloch, 2009). Investigations of the mechanism of mevalonic acid synthesis using enzymes of 
HMG-CoA reductase (HMGR) (Frimpon & Rodwell, 1994), which are key enzymes in sterol 
biosynthesis, established that the conversion of 3-hydroxy-3-metylglutaryl-coenzyme-A 
(HMGR-CoA) (main substrate) into mevalonate involves two molecules of 
nicotinamidedinucleotidephosphate (NADPH) (complementary substrate) and occurs 
through two sequential hydryl shifts. Although isoprenoids are necessary for normal cell 
function, an excess of certain products synthesized from mevalonate, e.g., cholesterol, can 
lead to progressive atherosclerosis and associated cardiovascular diseases. 
We examined the capability of synthetic LPYP, LPYPR, SPYPR, IAVP and their derivatives 
to occupy the binding site for NADPH which is one of the substrates of HMGR. We started 
with the knowledge that these peptides contain a proline unit [2] in the fourth residue from 
www.intechopen.com
 Soybean and Health 40
the N-terminus (this is the same in IAVP and IAVPTGVA or IAVPGEVA). Such a sequence 
may play an important role in HMGR inhibition (Pak et al, 2005a, 2005b). On the other hand, 
proline is the only unit with an aliphatic ring containing both the main and side chains. Its 
presence in the amino-acid sequence makes the conformation of the peptide relatively rigid. 
Thus, we assumed that proline in the above sequence can form a structure similar to the 
nicotinamide part [1] of NADPH and, therefore, has similar interactions with the binding 
site for nicotinamide in HMGR. We compared the peptide structures with those of the 
nicotinamide part of NADPH using data from an x-ray structure analysis of the enzyme 
active center with NADP+ (Istvan & Deisenhofer, 2000a, 2000b; Istvan et al., 2000) and 
selected four atoms (C4, O8, N9, O6’) with the shortest H-bond distances. The peptide 
structures and their conformations calculated using AM1, PM3 and MNDO (Pak et al., 
2005a, 2005b).  
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The steric similarity of these structures were determined by calculating the percent of the 
projections of the selected bonds of the peptides to the corresponding bonds in the 
nicotinamide part of NADPH in two mutually perpendicular planes. The first plane passed 
through the pyridine ring of nicotinamide; the second, through C2’ of the ribose ring. Thus, 
the results indicate that these peptides have structural features similar to the nicotinamide 
part in the studied positions and correlate with the inhibitory ability of these peptides. 
Therefore, they may bind to the active center of HMGR and interact similarly with it as 
NADPH. Also, LPYP, LPYPR, IAVP, IAVPTGVA and IAVPGEVA may occupy the part of 
the binding site for NADPH in the active center of the enzyme. According to the 
mathematical model of the structure - activity relationship for these peptides, a hydrophobic 
part of these peptides is a required structural element for their biological activity, and the 
proline acts as a key component for these compounds to be recognized as residues for the 
nicotinamide part of the NADPH binding site (Pak et al., 2005b, 2006). Kinetic experiments 
support that these peptides inhibit HMGR competitively with respect to HMG-CoA and 
NADPH and interact with this enzyme like a bisubstrate (Pak et al., 2005d). 
7.2 Peptide modeling and designing 
7.2.1 Peptide design for competing with HMG-CoA 
Hypocholesteroemic peptides with HMGR (HMG–CoA reductase) inhibiting activity were 
isolated from soybean, and found to act as inhibitors by competing with NADPH binding at 
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the active site of HMGR due to the structural and conformation similarity between peptides 
and NADPH. Based on the structures and reaction mechanisms of isolated peptides and the 
bioactive conformation of statins (commercial simvastatin and rosuvastatin) that also act as 
competitive inhibitors of HMG-CoA for HMGR (Istvan & Deisenhofer, 2000a, 2000b), design 
of another type of peptide sequence was proposed competing with HMG-CoA rather than 
NADPH. The active space in peptide design was defined by using bioactive conformations 
of simvastatin and rosuvastatin extracted from the crystal structure of HMGR–statin 
complex as shown in Fig. 7 (Pak et al, 2006).  
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Fig. 7. Modeling of an ‘‘active space’’ in the binding site of HMGR using the bioactive 
conformations of simvastatin and rosuvastatin extracted from the crystal structure of 
HMGR–statin complexes (PDB codes: 1HW9 (simvastatin), 1DQA (rosuvastatin)). The 
tetrahedron 1-2-3-4 was used as a model of the ‘‘active space’’ in the present study (Pak et 
al., 2006). 
A conformational aspect relating to an analysis of the flexibility of the peptide molecules 
and their occupied volumes was applied to the peptide design by extrapolation from the 
bioactive conformation of statin molecules. The design criterion was formulated in terms of 
a proximity parameter (Pr), reflecting the probability of an active peptide conformation to 
approximate the statin (Pak et al., 2006). It led to the proposed modeling of the peptide 
sequence as a tetrapeptide with an E-residue in C-terminus and L-, I-, or Y-residues at the 
N-terminus (Pak et al., 2005b, Istvan et al., 2000). A- and V-residues have at least a steric 
effect due to their aliphatic side chains and were selected for introduction into positions 2 
and 3. Based on these considerations, nine peptides IAAE, LAAE, YAAE, IAVE, LAVE, 
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YAVE, IVAE, LVAE, and YVAE were chosen as candidate peptides for the peptide library. 
To elucidate a role of the E-residue in biological activities, the IAVA peptide was 
additionally selected. IAVP, having the highest inhibitory activity against HMGR among 
previously synthesized peptides (Pak et al., 2004), was chosen as a control compound to 
compare the biological activities of the newly designed peptides. Comparing the calculated 
Pr, four peptides (IAVE, YAVE, IVAE, and YVAE) from the library were selected and 
synthesized. This finding proposes that the obtained configurations of the peptide 
backbones can be seen as a basis to extend the peptide library in search of more active 
competitive inhibitors of HMG–CoA. Among all peptides, YVAE showed the greatest ability 
to inhibit HMGR. A kinetic analysis (Pak et al., 2006) revealed that this peptide is a 
competitive inhibitor of HMG–CoA with an equilibrium constant of inhibitor binding (Ki) of 
15.2±1.4 μM. The HMGR inhibitory activity of YVAE was about 10 times greater than LPYP: 
IC50 of YVAE for HMGR is 41.8 μM, whereas the IC50 for the original peptide LPYP is 484 
μM; a kinetic study showed that YVAE is a competitive inhibitor of HMGR. The calculated 
coefficient correlation (R) between log (IC50) and the inverse value of proximity parameter 
(1/Pr) was found to be 0.99, indicating a high degree of correlation and efficacy of the given 
approach in the peptide sequence design. 
7.2.2 Design of peptides conserving recognized residue  
Previously, the structure-functional analysis in IAVPTGVA and IAVPGEVA peptides by 
making mutant peptides by substituting some amino acids for alanine (A-substitution) 
revealed that the activities suggest that the P-residue (A-substitution with P) is a recognized 
residue for the nicotinamide part of the NADPH binding site, and that the T- and E-residues 
can be seen as mimics of an HMG-moiety for the HMG-CoA binding site (Pak et al., 2005b, 
2006). A conformational analysis revealed the existence of a ‘ǃ-turn’ structure in these 
peptide sequences (Pak et al., 2004). Thus, VPTG and VPGE fragments in IAVPTGVA and 
IAVPGEVA peptides isolated from soy protein by pepsin treatment were shown to play an 
important role as a recognition site for peptide activity. Based on the presuppositions, the 
maintained conformation close to the bioactive conformations of VPTG and VPGE 
fragments was the focus for developing lead peptide candidates, which include constrained 
structures (maintaining VPTG and VPGE fragments) in a recognized sequence through a 
number of peptides in the design of a competitive inhibitor. 
Location of the side chain of peptides was compared to that of iso-butyl (simvastatin) and 
the benzene ring of the 4-fluorophenyl radical of statins (rosuvastatin). The design criterion 
was formulated in terms of a ‘V’ parameter, reflecting an occupied volume in conformation 
space by an individual peptide adduced to the conformation space occupied by all peptide 
candidates from a library (Pak et al., 2007). Twelve peptide cycles were selected for the 
peptide library. Comparing the calculated ‘V’ parameters, two cyclic peptides (GLPTGG and 
GFPTGG) were selected as lead cycles from the library (Table 6). The constrained GLPTGG 
and GFPTGG peptides were designed according to obtain the most rigid peptide backbone 
(Pak et al., 2007). Based on sequences GLPTGG and GFPTGG, six linear peptides obtained 
by breaking the cycle at different positions were selected as lead peptide candidates. It is 
proposed that activities of the linear peptides based on an identical amino acid sequence, 
which are obtained from a less flexible peptide cycle, would be relatively higher than those 
obtained from more flexible cyclic peptides. The linear GFPTGG peptide, showing the 
highest inhibitory activity against HMGR, increases the inhibitory potency nearly tenfold 
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(Table 6). Kinetic analysis reveals that the GFPTGG peptide is a competitive inhibitor of 
HMG-CoA with an equilibrium constant of inhibitor binding (Ki) of 6.4±0.3 μM and IC50 of 
GFPTGG for HMGR is 16.9 μM. CD spectra GFPTGG peptide in the TFE/water mixture, 
type II of the β-turn was considered as a major structural element in these peptides (Pak et 
al., 2007).  
 
Peptide  Position IC50 [μM] 
Set 5 4 3 2 1 1’ 2’ 3’ 4’ 5’ 
Cyclic    G L P T G G   46 
    G F P T G G   47 
    G W P T G G   82 
Linear     L P T G G G  84 
 1    F P T G G G  60 
     W P T G G G  357 
    G L P T G G   19 
 2   G F P T G G   17 
    G W P T G G   137 
   G G L P T G    54 
 3  G G F P T G    48 
   G G W P T G    297 
   G G L P T G G G  328 
 4  G G F P T G G G  299 
  G G G L P T G G G G 801 
  G G G F P T G G G G 698 
Controla   I A V P T G V A  152 
   I A V P G E V A  201 
Negative control   I A V T P G V A  Inactive 
aThe previously isolated peptides (Pak et al., 2005c). 
Table 6. Sequence structures and inhibitory activities (IC50) of the synthesized peptides used 
in this study 
7.2.3 Modeling of an active backbone of peptide 
A structure-function analysis of synthesized peptides proposes that a competitive inhibitory 
peptide can be designed by maintaining bioactive conformation in a recognized sequence as 
an aspect of the structure-based approach. A two-stage approach was applied in the peptide 
library design: The first was the modeling of the peptide backbone of a competitive 
inhibitory peptide in the active site of HMGR using previously designed peptides; The 
second stage was the design of new peptide libraries in order to evaluate the effects of the 
functional residue on peptide affinity. These applications utilized two different approaches 
in the design of constrained and unconstrained peptides in the investigation of the peptide 
binding effect for HMGR.  
Based on the modeling of an active peptide backbone in the active site of HMGR, two 
peptide libraries for constrained and unconstrained peptides were designed using different 
amino acids varying in hydrophobicity and electronic properties. IAVP and the peptides 
IAVE, YAVE, IVAE, and YVAE as competitive inhibitors of NADPH and HMG-CoA, 
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respectively, were selected by the design approach for unconstrained peptides (Pak et al., 
2006). GLPTGG and GFPTGG, acting as a bisubstrate-mimic, were chosen among designed 
peptides, having the most constrained structures (Fig. 8) (Pak et al., 2008a). Active peptides 
were selected by the design parameter ‘V’ or ‘Pr’, which reflects the probability of active 
peptide conformations for constrained and unconstrained peptides, respectively. (Table 7) 
(Pak et al., 2006, 2007). According to the ‘Pr’ value, FVAE and F(4-Fluoro)VAE have 
relatively higher values compared with WVAE and halogen-containing peptides, 
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Fig. 8. Models of HMG-CoA competitive inhibitory peptides (a) and peptide acting as a 
bisubstrate (b). (a) Model of an ‘active space’ (tetrahedron 1-2-3-4) based on a superposition 
of the bioactive conformations of simvastatin and rosuvastatin extracted from the crystal 
structure of HMGR–statin complex (PDB codes: 1HW9 (simvastatin), 1DQA (rosuvastatin)), 
and the average structures determined for IVAE and YVAE peptides. (b) Model of the type 
II ȡ-turn in peptide conformer (-H:-T) with an arrangement of peptide head (H-bold) and 
tail (T-short-dashed) relative to the plane passing through the three Ƞ-carbon of 2, 3, and 5 
atoms of the peptide backbone, and the peptide conformation (-H:-T) used in this study. The 
4–5 and 4–50 fragments in the peptide models were fixed as an HMG-mimic during 
modeling (Pak et al., 2008a). 
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respectively (Pak et al., 2008a). By considering the ‘V’ parameter, the GFPDGG and 
GFPEGG sequences are the most rigid structures compared to the other peptides, 
respectively. By considering the ‘V’ parameter, the GFPDGG and GFPEGG sequences are 
the most rigid structures compared to the other peptides (Pak et al., 2008a). Each of the 
synthesized peptides showed an ability to inhibit HMGR, with the exception of the GVAE 
and GGPTGG peptides (Table 7). The activities of the GVAE and GGPTGG peptides were 
not detectable, even at high concentrations. This indicates that the location of the I-, L-, F- 
and Y-side chains plays an important role in the peptide–protein interaction in the active 
site of HMGR. The GFPDGG peptide (IC50 = 1.5 μM), designed on the basis of the rigid 
peptide backbone, increases the inhibitory potency more than 300 times compared to the 
first isolated LPYP peptide (IC50 = 484 μM) from soybean. The obtained data suggest the 
possibility of designing a highly potent inhibitory peptide for HMGR and confirms that 
changes in the secondary structure of the enzyme play an important role in the mechanism 
of HMGR inhibition. 
 
Peptide sequence Peptide description IC50 (μM) 
LPYP Peptide isolated from soybean by trypsin 484.7 
IAVPGECA Peptide isolated from soybean by pepsin 152.1 
Unconstrained peptide   
IAVP NADPH competitive inhibitor 97.1 
IAVE HMG-CoA competitive inhibitor 75.2 
YAVE HMG-CoA competitive inhibitor 52.6 
IVAE HMG-CoA competitive inhibitor 44.1 
YVAE HMG-CoA competitive inhibitor 41.8 
FVAE HMG-CoA competitive inhibitor 43.8 
F(4-Fluore)VAE HMG-CoA competitive inhibitor 3.8 
GVAE Negative control (I- and Y- side chains) Inactive 
Constrained peptide   
GLPTGG NADPH and HMG-CoA competitive inhibitor 19.4 
GLPDGG NADPH and HMG-CoA competitive inhibitor 22.3 
GLPEGG NADPH and HMG-CoA competitive inhibitor 27.2 
GFPTGG NADPH and HMG-CoA competitive inhibitor 16.9 
GFPDGG NADPH and HMG-CoA competitive inhibitor 1.5 
GFPEGG NADPH and HMG-CoA competitive inhibitor 1.7 
GGPTGG Negative control (I- and F- side chains) Inactive 
Table 7. Summary of the sequence structures and inhibitory activities (IC50) of the isolated 
and designed peptides used in this study (Pak et al., 2008a). 
7.2.4 Design of an active peptide using a model with fixing recognized residues 
In the proposed design, two binding site points were used: the first was derived from a 
relative assessment of the ‘‘region bioactivity,’’ in HMGR, through an analysis of the active 
structures of statins; the second from binding of the designed peptides inside the ‘‘region 
bioactivity’’ through a common point/site of the bioactive compounds and peptide structures. 
Under these points, the peptide conformations fixed by active/recognized residues can be 
seen as an approach to model the restricted flexibility of the peptides in accordance with the 
conformational requirements imposed by the ‘‘region bioactivity’ (Pak et al., 2008b).  
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In order to design a linear peptide with an unconstrained structure in a recognition 
sequence, two subsequent stages were applied based on the YVAE peptide as a basis of the 
recognition sequence: the first stage was to extend the peptide length for YVAE sequence in 
accordance with statin structures. For this purpose, structures of all statin molecules 
extracted from the crystal structures of HMGR–statin complexes were analyzed while 
focusing on the structural diversity of the rigid hydrophobic groups. The second stage was 
to investigate the conformational behavior of the peptide models. A principle component 
analysis (PCA), which projects multidimensional data on low-dimensional subspace, was 
used to evaluate a head-to-tail peptide cycle as a model of linear analog in order to select a 
lead peptide candidate. Using the space obtained (V parameter) by an analysis of the 
bioactive conformations of statins, eight cyclic peptides were selected for a peptide library 
based on the YVAE sequence as a recognized motif (Fig. 8). For each cycle, the four models 
were assessed according to the design criterion applied for constrained peptides. Three 
cyclic peptides (FGYVAE, FPYVAE, and FFYVAE) were selected as lead cycles from the 
library. The linear FGYVAE peptide (IC50 = 0.4μM) showed a 1,200-fold increase in 
inhibitory activity compared to the first isolated LPYP peptide (IC50 = 484μM) from soybean 
(Table 8). Experimental analysis of the modeled peptide structures confirms the 
appropriateness of the proposed approach for the modeling of active conformations of 
peptides (Pak et al., 2008b).  
 
Peptides Peptide sequence Fixed residues in set IC50 (μM) 
1 2 3 4 
Design 
 
 
 
 
 
Control 
 
 
 
Negative control 
GGYVAE 
FFYVAE 
FPYVAE 
FGYVAE 
FWYVAE 
GGGGYVAE 
IAVPTGVA 
IAVPGEVA 
LPYPa 
YVAEb 
FGYVAA 
E
E
E
E
E
E
T
E
EA
EA
EA
EA
EA
EA
TG
EV 
 
 
 
EAV 
EAV 
EAV 
EAV 
EAV 
EAV 
TGV 
EVA 
 
 
 
EAVY 
EAVY 
EAVY 
EAVY 
EAVY 
EAVY 
TGVA 
EVAI 
 
 
 
7.4 
2.5 
1.4 
0.4 
29.5 
760.7 
152.1 
201.3 
484.7 
41.9 
Inactive 
aThe LPYP peptide was found by analysis of a digested soy glycinin using trypsin (Kwon et al., 2002).  
bThe YVAE peptide was used as a basis of the recognized sequence, which presents an unconstrained 
peptide structure (Pak et al., 2006). 
Table 8. Peptide sequences, peptide models and inhibitory activities (IC50) of the synthesized 
peptides used in this study 
7.2.5 Peptide fragmentation for design of peptides 
In a previous design, while searching for lead peptide candidates, the efficacy of a design 
approach based on the use of a cyclic peptide as a model of linear analog was demonstrated 
(Valero, et al., 2000). The conformational behavior of the cyclic peptides showed that the 6-
membered cyclic peptide was relatively stable compared to the 8-, and 10-membered cyclic 
peptides (Pak et al., 2010). Analysis of the conformational behavior of the peptide models 
showed that an analogical approach could be applied in order to assess the conformational 
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Peptide sequence Peptide fragment IC50 (μM) 
1 2 3 4 5 
Controla       
LPYP LPYP     484.72 
IAVPGEVA IAVP AVPG VPGE PGEV GEVA 201.12 
IAVPTGVA IAVP AVPT VPTG PTGV TGVA 152.19 
       
Set 1b       
GLPTGG GLPT LPTG PTGG   19.43 
GLPDGG GLPD LPDG PDGG   22.31 
GLPEGG GLPE LPEG PEGG   27.28 
GFPTGG GFPT FPTG PTGG   16.94 
GFPDGG GFPD FPDG PDGG   1.52 
GFPEGG GFPE FPEG PEGG   1.78 
GXPTGGd GXPTd XPTGd PTGG   4.82 
GXPDGGd GXPDd XPDGd PDGG   6.95 
GXPEGGd GXPEd XPEGd PEGG   0.75 
GXPGGGd Negative control Inactive 
       
Set 2c       
IAVE   IAVE   75.23 
IVAE   IVAE   52.67 
YAVE   YAVE   44.81 
YVAE   YVAE   41.21 
FFYVAE FFYV FYVA YVAE   2.56 
FPYVAE FPYV PYVA YVAE   1.47 
FGYVAE FGYV GYVA YVAE   0.41 
XVAEd    XVAEd  3.84 
FGXVAEd  FGXVd GXVAd XVAEd  8.52 
GFGYVAE GFGY FGYV GYVA YVAE  0.27 
TFGYVAE TFGY FGYV GYVA YVAE  0.26 
DFGYVAE DFGY FGYV GYVA YVAE  0.16 
EFGYVAE EFGY FGYV GYVA YVAE  0.24 
DFGYVAG Negative control Inactive 
a ‘Control’ contains the peptides isolated from soy protein (Kwon et al, 2002; Pak et al., 2005b, c). 
b ‘Set 1’ contains the peptides, which includes the recognized T, D or E residue as a corner residue of the 
ȡ-turn structure (Pak et al., 2007, 2008a). 
c ‘Set 2’ contains the peptides, where the E residue is a recognized residue for the HMG-binding pocket, 
and a ȡ-turn structure is located in the N-terminus of the hexapeptides (Pak et al., 2008b). 
dThe substituted (4-fluoro)phenylalanine residue is indicated as ‘X‘. 
Table 9. Peptide sequence, peptide fragment, and inhibitory activities (IC50) of the 
synthesized peptides (Pak et al., 2010). 
space that was occupied by a peptide by using peptide fragments. In order to assess the 
proposed method, a competitive inhibitor for HMGR was designed by using two starting 
points: (1) determined recognition residues and (2) the structural preference of a peptide, 
such as a ǃ-turn conformation in the present design. For testing the proposed design, 13 
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peptides that were designed in previous studies were used (Pak et al., 2007, 2008a, 2008b). 
These peptides were divided into two sets in accordance with the location of a ‘turn’ 
structure relative to the recognized residue that is essential for binding. Set 1 comprised six 
peptides: GLPTGG, GLPDGG, GLPEGG, GFPTGG, GFPDGG, and GFPEGG (Table 9).  
A common structural element of these peptides was a turn conformation, which included T, 
D, or E as a corner residue of the -turn structure and was recognized by a HMG-binding 
pocket. All peptides inhibited HMGR in a competitive manner. Set 2 included seven 
peptides, in which E residue was also a recognition residue for the HMG-binding pocket. A 
conformational analysis of the IAVE, IVAE, YAVE, and YVAE peptides revealed no 
observable patterns that were related to a well-populated secondary structure conformation 
(Pak et al., 2006). For the FFYVAE, FPYVAE, and FGYVAE peptides, a turn conformation 
was determined at the N-terminus of these peptides. All of these peptides presented as 
HMG-CoA competitive inhibitors (Pak et al., 2008b) (Table 9). 
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Fig. 9. Spatial compatibility of the linear GF(4-fluoro)PEGG and DFGYVAE peptides with 
atorvastatin. The alpha-carbon atoms are indicated by marks from 1 to 6 for the GF(4-
fluoro)PEGG peptide and from 10 to 70 for the DFGYVAE peptide. The model of GF(4-
fluoro)PEGG was built as type II of the ǃ-turn on the basis of the fixed backbone dihedral 
angles adopted by the two corner proline and glutamic acid residues (φi+1 = -60°, ψi+1 = 120°, 
φi+2 = 80°, and ψi+2 = 0°). For the DFGYVAE peptide, the model was constructed as type I of 
the ǃ-turn by using the fixed backbone dihedral angles adopted by the two corner glycine 
and tyrosine residues (φi+1 = -60°, ψi+1 = -30°, φi+2 = -90°, and ψi+2 = 0°). The orientations of the 
side-chains and other residues were determined by an optimization procedure. 
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Two sets of peptides were developed based on the different locations of a ǃ-turn structure 
relative to a recognition residue (Table 9). Set 1 contains peptides in which a recognition 
residue is included in turn conformation. In Set 2, the ǃ-turn structure is located distantly 
from the recognition residues. The design parameter ‘V’ that was applied in previous 
studies was slightly modified for the purpose of the current research. The 17 previously and 
8 newly designed peptides were estimated by this parameter. In each set, one sequence was 
selected as a lead peptide candidate for each set: GF(4-fluoro)PEGG for Set 1 and DFGYVAE 
for Set 2. The inhibitory activities improved in each set, the proposed contribution of the 
fluorine atom of GF(4-fluoro)PEGG peptide during binding led to an increase in the 
inhibitory activity for this peptide compared to the other members of Set 1 (Fig. 9). This was 
explained by a similar location of the 4-fluorophenyl group of atorvastatin and GF(4-
fluoro)PEGG peptide. Probably, the increase of inhibitory activity of the DFGYVAE peptide 
can be interpreted in terms of the contribution of the oxygen atom of the carbonyl group of 
the D side chain, while the increase of inhibitory activity of the GFGYVAE peptide by the 
contribution of the oxygen atom from the amide bond between N-terminus’ G and F 
residues in binding. The IC50 for the GF(4-fluoro) PEGG peptide was found to be 0.75μM, 
while the linear DFGYVAE peptide (IC50 = 0.16μM) showed a 3,000-fold increase in 
inhibitory activity compared to the first isolated LPYP peptide (IC50 = 484μM) from 
soybeans. The comparison of the structure–activity relationship (SAR) data between Set 1 
and 2 provided an opportunity to design the peptides in terms of peptide selectivity.  
In conclusion, the present study not only shows the design of a more potent inhibitor for 
HMGR, but also defines a design tool to model active conformations for linear peptides.  
8. Conclusions 
One possible reason for the lower incidence of some diseases such as obesity, diabetes, or 
even breast cancers among Asians is that they consume fermented soybean products, which 
are unique to traditional Asian diets. Asians have prepared and eaten their own soy 
products such as tofu and fermented soy products for thousands of years. Soybean 
fermented foods such as doenjang (long-term fermented soy products), chungkukjang 
(short-term fermented soy products), kanjang (fermented soy sauce) are highlighted due to 
their healthy functionalities. Both short- and long-term fermented soybeans contain more 
beneficial components to ameliorate metabolic disorders than unfermented soybeans. The 
changes in nutritive and non-nutritive biofactors during fermentation and their capacity for 
ameliorating metabolic disorders were reported in Asian countries, especially Korea. The 
changes in metabolomic profiling were analyzed using GC, LC, and NMR with mass 
spectrometry for the metabolites produced during the fermentation by Bacillus for a short-
term fermentation and Aspergillus for a long-term fermentation. Fermentation of soybeans 
increased isoflavonoid aglycones, modified isoflavonoids such as equol and small peptides 
and these changes enhanced the prevention of metabolic disorders. Chungkukjang and meju 
improved anti-diabetic action by improving ǃ-cell function and mass via potentiating 
insulin/IGF-1 signaling in the islets. Thus, daily consumption of fermented soybean 
products can prevent and/or delay metabolic disorders in humans. From fermented 
soybeans we found some effective peptides for reducing the hypertension and 
hypercholesterolemia by analyzing ACE (angiotensin converting enzyme) inhibition and 
HMG(3-hydroxy-3-methylglutaryl)-CoA reductase inhibition, respectively. Active 
hypotensive and hypocholesterolemic peptides were isolated and structures identified as 
HHL for hypotensive, and LPYP and IAVPGEVA for hypocholesterolemic peptide, 
respectively. Based on the conformation of these peptide structures and mechanisms of the 
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reactions, new peptides were designed using peptide modeling to strengthen their activity 
as candidates for a new drug and nutraceuticals. Novel peptide (DFGYVAE) was designed 
to increase the hypocholesterolemic effectiveness to three thousand times higher than origin 
peptide (LPYP). Currently the peptides from soy or other beans can be the subject of 
investigation for new drugs and functional food ingredients for gut health and modulating 
the intestinal absorption of nutrients. Research into bioactive soy peptides is still in its 
infancy, but holds great promise.  
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